DelveInsight’s, “Dry Age-Related Macular Degeneration Pipeline Insight 2023,” report provides comprehensive insights about 58+ companies and 64+ pipeline drugs in the Dry Age-Related Macular Degeneration pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. […]
Inhibikase Therapeutics, Inc. (Nasdaq: IKT) stock gained on Wednesday despite another bearish day in the broader markets, moving higher by about 3% and, at press time, adding another 5% to that increase. The bullish sentiment makes sense even in the face of market turmoils. IKT scored massively positive news from the FDA when it announced […]
The Company unveils brand name for its planned minoxidil hair regrowth product LOS ANGELES – March 16, 2023 – ViaDerma, Inc. (OTC Pink: VDRM) is pleased to announce that the company has recently submitted its application for its planned minoxidil hair regrowth product for FDA registration status approval. The FDA registration process should be relatively […]
Europe accounted for 32.5% of the market during the forecast period. The increasing incidence of dental caries and various periodontal diseases is driving the demand for dental procedures and products, such as prosthetics and implants, in Europe. Browse 224 market data Tables and 62 Figures spread through 299 Pages and in-depth TOC on “Dental Laboratories […]
The Pouchitis market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Pouchitis pipeline products will significantly revolutionize the Pouchitis market dynamics. DelveInsight’s “Pouchitis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Pouchitis, historical and forecasted epidemiology as well […]
Las Vega (Nevada), United States //— As per DelveInsight’s assessment, globally, Pancreatic Ductal Adenocarcinoma pipeline constitutes 80+ key companies continuously working towards developing 80+ Pancreatic Ductal Adenocarcinoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. Pancreatic Ductal Adenocarcinoma Overview Pancreatic ductal adenocarcinoma (PDAC) is a highly […]
The Parkinson’s Disease Levodopa-Induced Dyskinesia market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Parkinson’s Disease Levodopa-Induced Dyskinesia pipeline products will significantly revolutionize the Parkinson’s Disease Levodopa-Induced Dyskinesia market dynamics. DelveInsight’s “Parkinson’s Disease Levodopa-Induced Dyskinesia Market Insights, Epidemiology, and Market Forecast-2032″ report offers […]
The Postpartum Depression market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Postpartum Depression pipeline products will significantly revolutionize the Postpartum Depression market dynamics. DelveInsight’s “Postpartum Depression Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Postpartum Depression, historical […]
Acurx Pharmaceuticals’ (NASDAQ: ACXP) earnings release is scheduled for Thursday, March 16, 2023. And like most biotechs, investors will be more focused on what the company says than what it posts. That’s typical. Clinical-stage drug development companies rarely post meaningful revenues. But, they provide guidance and clinical program updates, two areas where investors can appraise […]
McKesson Corporation (US) dominated the global patient access solutions market in 2021. The company operates its business through four reportable segments, namely, US Pharmaceutical, Medical-Surgical Solutions, Prescription Technology Solutions, and International. Patient access solutions are offered under the US Pharmaceutical segment. Patient Access Solutions Market is projected to grow from USD 1.9 billion in 2022 […]
